Literature DB >> 367432

Evaluation of a 5% guanethidine and 0.5% adrenaline mixture (Ganda 5.05) and of a 3% guanethidine and 0.5% adrenaline mixture (Ganda 3.05) in the treatment of open-angle glaucoma.

J Romano, G Patterson.   

Abstract

A trial of a mixture of guanethidine 5% and adrenaline 0.5% (Ganda 5.05) and of guanethidine 3% and adrenaline 0.5% (Ganda 3.05) was conducted on 90 eyes in 53 patients with open-angle glaucoma or ocular hypertension. The cases fell into 5 groups: untreated cases, cases on pilocarpine 1%, on pilocarpine 2%, on pilocarpine 2 to 4% and adrenaline 1%, and on separate guanethidine 5% and adrenaline 1%. Baseline pressures and average pressures on the previous treatment were established. Substitution with Ganda 3.05 or 5.05 was started, and the patients attended 2 weeks, 1 month, 3 months, and 6 months from the start of the trial. Applanation tonometry was carried out at the same time of day. The pupil was measured, ptosis and superficial punctate corneal staining were looked for and evaluated, and the patients were questioned for symptoms of side effects and acceptability. All the eyes that had previously been treated with pilocarpine 1% or 2% presented significantly lower intraocular pressures on Ganda 3.05. The patients on pilocarpine 4% and adrenaline 1% also had lower intraocular pressures on Ganda 5.05, but the significance was less, and the patients on separate guanethidine and adrenaline had a small but not statistically significant drop in pressure. Ptosis and discomfort were evaluated on a subjective scale. Patient acceptability was good. The trial was interrupted in 5 cases for various reasons. Tachyphylaxis and tolerance to the mixtures were not observed in this series.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 367432      PMCID: PMC1043387          DOI: 10.1136/bjo.63.1.52

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Guanethidine and aqueous humor dynamics.

Authors:  J A CASTREN; S POHJOLA
Journal:  Acta Ophthalmol (Copenh)       Date:  1962

2.  Low centration guanethidine and adrenaline therapy of glaucoma. A preliminary report.

Authors:  S Nagasubramanian; R C Tripathi; D Poinoosawmy; J Gloster
Journal:  Trans Ophthalmol Soc U K       Date:  1976-04

3.  Use of guanethidine 5% and adrenaline 1% in the treatment of severe open angle glaucoma.

Authors:  J Romano
Journal:  Trans Ophthalmol Soc U K       Date:  1977-04

4.  Guanethidine and adrenaline used in combination in chronic simple glaucoma.

Authors:  J A Roth
Journal:  Br J Ophthalmol       Date:  1973-07       Impact factor: 4.638

5.  Drug therapy of glaucoma.

Authors:  G D Paterson; G Paterson
Journal:  Br J Ophthalmol       Date:  1972-03       Impact factor: 4.638

6.  Adrenergic supersensitization as a therapeutic tool in glaucoma.

Authors:  A L Crombie
Journal:  Trans Ophthalmol Soc U K       Date:  1974-07

7.  Guanethidine and glaucoma.

Authors:  J Gloster
Journal:  Trans Ophthalmol Soc U K       Date:  1974-07

8.  Action of drugs on the aqueous flow in man measured by fluorophotometry.

Authors:  P Anselmi; A J Bron; D M Maurice
Journal:  Exp Eye Res       Date:  1968-10       Impact factor: 3.467

  8 in total
  3 in total

1.  Control of glaucoma by reduced dosage guanethidine-adrenaline formulation.

Authors:  D E Jones; D A Norton; D J Davies
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

2.  A long term study of low concentration guanethidine and adrenaline therapy in glaucoma.

Authors:  S Nagasubramanian; J Gloster; D Poinoosawmy; R Watkins
Journal:  Int Ophthalmol       Date:  1980-12       Impact factor: 2.031

3.  Double-masked cross-over comparison of Ganda 1.02 (guanethidine 1% and adrenaline 0.2% mixture) with gutt. adrenaline 1% (Simplene 1%) and with pilocarpine 1% (Sno-Pilo 1%).

Authors:  J H Romano; S Nagasubramanian; D Poinoosawmy
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.